Suppression of Tumor Cell Immune Counterattack by Blocking FasL Expression in Pancreatic Cancer Cells

徐伟,徐高四,虞春华,刘巧云,方义湖

DOI: https://doi.org/10.3969/j.issn.1673-5269.2008.18.008

2008-01-01

Abstract:OBJECTIVE: To investigate if the supression of FasL expression in pancreatic cancer cells can inhibite tumor cell immune in vivo.METHODS: A cDNA fragment complementary,when transcribed,from nucleotides 35 to 371 of the mouse FasL mRNA sequence was amplified by PCR.The fragment was cloned into the StuI site of pBlast expression vector.Panc-1 cells were transfected with plasmid DNA.The suppression of FasL expression in stably transfected clones was determined by Western blot for FasL protein.Soluble FasL was detected in the culture supernatant of Panc-1 cells by ELISA.C57BL/6 mice were injected with tumor cells suspended.Tumor growth was monitored by measuring the width and length of the tumors.The level of lymphocyte infiltration in the excised tumors was assessed.RESULTS: FasL expression in hepatic cancer cells was down-regulated following stable transfection with a plasmid encoding antisense FasL cDNA,and with 80% decrease of FasL expression in plasmidtrans-trans pected cells.Down-regulation of FasL expression on pancreatic cancer cells had no effect on tumor growth in vitro,but significantly reduced tumor development in syngeneic immunocompetent mice in vivo.Mean tumor diameters was 1.53 mm in the group transfected with plasmid DNA,versus 2.98 mm in the group not transfected with plasmid DNA,and the difference was significant between the two groups,P0.01.Compared with the group not transfected with plasmid DNA,the absolute number of CD45+ TIL was increased by 3.23 times in the group transfected with plasmid DNA,P0.01.CONCLUSION: Down-regulation of FasL expression by pancreatic cancer cells results in an improved anti-tumor immune challenge in vivo,providing experimental evidence for counterattack as a mechanism of tumor immune evasion.